These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37191923)

  • 1. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
    Wei H; Fu F; Jiang H; Wu Y; Qin Y; Wei H; Yang T; Wang M; Song B
    Eur Radiol; 2023 Nov; 33(11):7631-7645. PubMed ID: 37191923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.
    Wei H; Jiang H; Qin Y; Wu Y; Lee JM; Yuan F; Zheng T; Duan T; Zhang Z; Qu Y; Chen J; Chen Y; Ye Z; Yao S; Zhang L; Yang T; Song B
    Eur Radiol; 2022 Nov; 32(11):7578-7589. PubMed ID: 35554652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIVKA-II combined with tumor burden score to predict long-term outcomes of AFP-negative hepatocellular carcinoma patients after liver resection.
    Qiu ZC; Wu YW; Qi WL; Li C
    Cancer Med; 2024 Jan; 13(1):e6835. PubMed ID: 38130028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of tumor recurrence by α-fetoprotein model after curative resection for hepatocellular carcinoma.
    Ding HF; Zhang XF; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Lv Y; Pawlik TM
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):660-666. PubMed ID: 33082065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma.
    Yan X; Li Y; Qin W; Liao J; Fan J; Xie Y; Wang Z; Li S; Liao W
    BMC Cancer; 2024 Jun; 24(1):700. PubMed ID: 38849749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients.
    Lin KY; Chen QJ; Tang SC; Lin ZW; Zhang JX; Zheng SM; Li YT; Wang XM; Lu Q; Fu J; Guo LB; Zheng LF; You PH; Wu MM; Lin KC; Zhou WP; Yang T; Zeng YY
    BMC Cancer; 2023 Dec; 23(1):1190. PubMed ID: 38053048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma.
    Li WF; Yen YH; Liu YW; Wang CC; Yong CC; Lin CC; Cheng YF; Wang JH
    Updates Surg; 2022 Aug; 74(4):1345-1352. PubMed ID: 34374920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 10. Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
    Tsilimigras DI; Mehta R; Paredes AZ; Moris D; Sahara K; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Spolverato G; Umberto C; Pawlik TM
    Ann Surg; 2020 Oct; 272(4):574-581. PubMed ID: 32932309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
    Huang J; Liu FC; Li L; Zhou WP; Jiang BG; Pan ZY
    Cancer Med; 2020 Apr; 9(8):2791-2802. PubMed ID: 32096346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors.
    Zhu HF; Feng JK; Xiang YJ; Wang K; Zhou LP; Liu ZH; Cheng YQ; Shi J; Guo WX; Cheng SQ
    BMC Cancer; 2023 Jun; 23(1):547. PubMed ID: 37322411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
    Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
    Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis.
    Chen YS; Hsieh PM; Lin HY; Hung CM; Lo GH; Hsu YC; Lu IC; Lee CY; Wu TC; Yeh JH; Hsiao P; Li YC; Wang YC; Hsieh KC; Lin CW
    BMC Gastroenterol; 2021 May; 21(1):220. PubMed ID: 33990184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI radiomics based on deep learning automated segmentation to predict early recurrence of hepatocellular carcinoma.
    Wei H; Zheng T; Zhang X; Wu Y; Chen Y; Zheng C; Jiang D; Wu B; Guo H; Jiang H; Song B
    Insights Imaging; 2024 May; 15(1):120. PubMed ID: 38763975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
    Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
    BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma.
    Lima HA; Endo Y; Moazzam Z; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Endo I; Kitago M; Shen F; Pawlik TM
    J Surg Oncol; 2023 Mar; 127(3):374-384. PubMed ID: 36194039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
    Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
    JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
    Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
    Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.